In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
about
Vaccine adjuvants: mode of actionAdvances in aluminum hydroxide-based adjuvant research and its mechanismMicroparticles as vaccine adjuvants and delivery systems.In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particlesComparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment.Developing a vaccine against multiple psychoactive targets: a case study of heroin.Adjuvants for Leishmania vaccines: from models to clinical application.Beyond antigens and adjuvants: formulating future vaccines.Vaccine delivery using nanoparticles.Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environmentImproving vaccines by incorporating immunological coadjuvants.Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation.Engineering synthetic vaccines using cues from natural immunity.The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.Protein adsorption and displacement at lipid layers determined by total internal reflection fluorescence (TIRF).Vaccine developments.Nanocarrier-Integrated Microspheres: Nanogel Tectonic Engineering for Advanced Drug-Delivery Systems.Interleukin-4- and NACHT, LRR and PYD domains-containing protein 3-independent mechanisms of alum enhanced T helper type 2 responses on basophils.High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
P2860
Q21131210-F896CFA8-71CB-4851-9B16-063558AA350FQ27007659-5FE90385-CB02-4DD4-8140-6DB817282B8DQ35192199-DDB987D8-F221-4E10-9DB9-48CB649670E3Q35229225-2F0BA074-7289-4B0E-86E5-126922E3E769Q35887653-29BC4CD8-9C18-4CE5-8B95-D401F94A5BD6Q35892296-12E86DD5-3EC9-4A58-9B95-E2371095EA6EQ36021357-DBA57E97-BB2E-47D2-8193-0FBAD236DD86Q36618500-7A8CD37F-AAD4-466E-A3A8-8A9BEDAFE672Q36712817-299A061B-48D5-43A4-A943-AE09D79FF7ECQ36766169-D603AA0E-5174-48F7-BB18-F01A93BD0237Q36899084-917C19DA-2EDE-4A8A-A3E3-6FD433D8C60EQ36968256-29C3D792-736E-42EF-AA02-AD277D34FA57Q38154804-87862420-29BB-4BE8-AC19-E2AC1F74A921Q38453147-31E42E37-F9F6-4967-B0A9-B08744EC8237Q40752357-2124239E-198B-4851-928E-84A990B1F112Q45974650-D99AD1F5-56B8-4850-B95D-4081386BAB37Q46448539-23A0712D-2947-4655-BD9B-59B705E0E3D1Q50952828-2BC40B58-9384-44FF-AE41-0B036BB5A106Q51697509-74F4D3E4-3AFF-4579-B8F5-841A00416129Q57462700-3790A06F-21A8-46BA-B97D-5DAAD9F0A629
P2860
In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@ast
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@en
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@nl
type
label
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@ast
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@en
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@nl
prefLabel
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@ast
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@en
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@nl
P2093
P1433
P1476
In vivo distribution of radioa ...... ng 14C-labeled tetanus toxoid.
@en
P2093
P304
P356
10.1016/S0264-410X(96)00073-4
P407
P577
1996-10-01T00:00:00Z